MADRIGAL PHARMACEUTICALS, INC. (MDGL) /
The cash flow of MADRIGAL PHARMACEUTICALS, INC. over the past 10 years
Chart MADRIGAL PHARMACEUTICALS, INC.: operating cash flow, capital expenditures, free cash flow, fiscal 2016–2025 Open the chart →In fiscal 2025, the latest fiscal year on file, MADRIGAL PHARMACEUTICALS, INC.'s operating cash flow was -$189.55M and its capital expenditures $467K, leaving free cash flow of -$190.02M. Free cash flow was below zero in all 10 years shown. It ranged from -$457.03M in fiscal 2024 to -$17.61M in fiscal 2016. Capital expenditures were highest in fiscal 2023, at $1.48M.
Year by year
| Fiscal year | Operating cash flow | Capital expenditures | Free cash flow* |
|---|---|---|---|
| 2025ended Dec 31, 2025 | -$189.55M | $467K | -$190.02M |
| 2024ended Dec 31, 2024 | -$455.57M | $1.46M | -$457.03M |
| 2023ended Dec 31, 2023 | -$324.23M | $1.48M | -$325.71M |
| 2022ended Dec 31, 2022 | -$224.86M | $217K | -$225.07M |
| 2021ended Dec 31, 2021 | -$183.92M | $209K | -$184.13M |
| 2020ended Dec 31, 2020 | -$157.56M | $334K | -$157.9M |
| 2019ended Dec 31, 2019 | -$41.62M | $172K | -$41.8M |
| 2018ended Dec 31, 2018 | -$25.51M | $22K | -$25.53M |
| 2017ended Dec 31, 2017 | -$22.32M | $125K | -$22.44M |
| 2016ended Dec 31, 2016 | -$17.61M | $3K | -$17.61M |
Fiscal years as MADRIGAL PHARMACEUTICALS, INC. reports them. * Calculated by us from the company's filed figures; — no figure on file. From SEC filings, updated nightly. How each line is read.
More on MADRIGAL PHARMACEUTICALS, INC.
- The revenue of MADRIGAL PHARMACEUTICALS, INC.
- The profitability of MADRIGAL PHARMACEUTICALS, INC.
- The debt of MADRIGAL PHARMACEUTICALS, INC.
- All of MADRIGAL PHARMACEUTICALS, INC.'s financials, charted
Companies of a similar size
- SITMSiTime Corporation
- SWKSSKYWORKS SOLUTIONS, INC.
- BSYBENTLEY SYSTEMS, INCORPORATED
- HCMHutchMED (China) LIMITED
- DTMDT Midstream, Inc.
Not investment advice. This page shows what MADRIGAL PHARMACEUTICALS, INC. filed with the SEC. Nothing here is a recommendation about any security. Check important figures against the company's own filings.